John Trainer - Apr 8, 2021 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Financial Officer
Signature
/s/ Ilse Johnson, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Apr 8, 2021
Transactions value $
$35,487
Form type
4
Date filed
5/19/2021, 04:16 PM
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Options Exercise $17.7K +3.43K +7.14% $5.17* 51.5K Apr 8, 2021 Direct
transaction NEXI Common Stock Options Exercise $17.7K +3.43K +6.67% $5.17* 54.9K May 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Options Exercise $0 -3.43K -2.94% $0.00 113K Apr 8, 2021 Common Stock 3.43K $5.17 Direct F1
transaction NEXI Stock Option (right to buy) Options Exercise $0 -3.43K -3.03% $0.00 110K May 8, 2021 Common Stock 3.43K $5.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.